Tenapanor for the Treatment of Hyperphosphatemia in Japanese Hemodialysis Patients: A Randomized Phase 3 Monotherapy Study With an Up-titration Regimen.

Fukagawa, Masafumi; Urano, Natsuki; Ikejiri, Kazuaki; Kinoshita, Jun; Nakanishi, Kaoru; Akizawa, Tadao

Fukagawa, Masafumi; Urano, Natsuki; Ikejiri, Kazuaki; Kinoshita, Jun; Nakanishi, Kaoru; Akizawa, Tadao.

Afiliação

Fukagawa M; Division of Nephrology, Endocrinology, and Metabolism, Department of Internal Medicine, Tokai University School of Medicine, Kanagawa, Japan. Electronic address: fukagawa@tokai-u.jp.
Urano N; R&D Division, Kyowa Kirin Co, Ltd, Tokyo, Japan.
Ikejiri K; R&D Division, Kyowa Kirin Co, Ltd, Tokyo, Japan.
Kinoshita J; R&D Division, Kyowa Kirin Co, Ltd, Tokyo, Japan.
Nakanishi K; R&D Division, Kyowa Kirin Co, Ltd, Tokyo, Japan.
Akizawa T; Division of Nephrology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.

Am J Kidney Dis ; 82(5): 635-637, 2023 Nov.

Article em En | MEDLINE | ID: mdl-37330134

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Am J Kidney Dis Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google